Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Filings indexed 1,617 across all filing types
Latest filing 2019-11-13 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
108年第3季財務報告書 — 201904_3164_AI3.pdf
Regulatory Filings
2019-11-13 Chinese
108年第3季財務報告書 — 201904_3164_AI1.pdf
Regulatory Filings
2019-11-13 Chinese
108年第3季財務報告書 — 201903_3164_AI1.pdf
Regulatory Filings
2019-11-13 Chinese
108年第3季財務報告書 — 201902_3164_AI1.pdf
Regulatory Filings
2019-11-13 Chinese
108年第3季財務報告書 — 201901_3164_AI1.pdf
Regulatory Filings
2019-11-13 Chinese
108年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts, investment methods, and related financial figures concerning investments in mainland China by a Taiwanese listed company. It includes specific financial data such as capital amounts, investment gains/losses, and cumulative investment limits approved by the Economic Ministry. The document is relatively short (1428 characters) and focuses on investment details rather than a full financial report or announcement. It does not appear to be an annual or interim report, earnings release, or management discussion. It is a regulatory disclosure related to investment activities, likely a regulatory filing to comply with investment reporting requirements. There is no indication that this is an announcement of a report publication or a certification letter. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory disclosures that do not fit other categories.
2019-11-13 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.